Comparative outcome and prognostic factor analysis among MDS/AML patients with TP53 mutations, snps, and wild type
Abstract While variant TP53 is an adverse prognosis factor in myelodysplastic syndromes (MDS)/acute myeloid leukemia (AML), current clinical prognosis and variation feature analysis of TP53 alterations remain limited. We evaluated 333 MDS/AML patients with TP53 mutations, single nucleotide polymorph...
Zapisane w:
| Główni autorzy: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BMC
2025-08-01
|
| Seria: | Human Genomics |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1186/s40246-025-00792-z |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|